Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemia

Journal of the Neurological Sciences

Volumn 162, Issue 2, 1999, Pages 114-119

  Leker, Ronen R ^a   Shohami, Esther ^a   Abramsky, Oded ^a   Ovadia, Haim ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Dexanabinol; Ischemia; Nitric oxide synthase; Stroke; TNF

Indexed keywords

ANTIOXIDANT; ARGININE; CITRULLINE; DEXANABINOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN HOMOGENATE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; STROKE;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EXCITATORY AMINO ACID ANTAGONISTS; HYPERTENSION; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED SHR; TETRAHYDROCANNABINOL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033556581     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00301-3     Document Type: Article

References (29)

1. Arvin B, Neville LF, Barone FC, Feuerstein GZ The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev. 20:1996;445-452.
2. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke. 28:1997;1233-1244.
3. Belayev L, Bar Joseph A, Adamchik J, Biegon A HU-211, a nonpsychotropic cannabinoid, improves neurological signs and reduces brain damage after severe forebrain ischemia in rats. Mol Chem Neuropathol. 25:1995;19-33.
4. Biegon A Neuroprotective activity of HU-211, a novel nonpsychotropic synthetic cannabinoid. Ann NY Acad Sci. 765:1995;314.
5. Biegon A, Knoller N, Ehrenfreund N, Brewster M Pharmacokinetics of dexanabinol: effect of head trauma on drug disposition in patients. J Neurotrauma. 17:1997;758.
6. Brewster M, Pop E, Foltz R, Reuschel S, Griffin W, Amselem S, Biegon A Clinical pharmacokinetics of escalating i.v. doses of dexanabinol (HU-211), a neuroprotectant agent, in normal volunteers. Int J Clin Pharmacol. 35:1997;361-365.
7. Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med. 7(2):1997;788-794.
8. Choi DW Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab Rev. 2:1990;105-147.
9. Dalkara T, Moskowitz MA Neurotoxic and neuroprotective roles of nitric oxide in cerebral ischaemia. Int Rev Neurobiol. 40:1997;319-336.
10. Eshhar N, Striem S, Kohen R, Tirosh O, Biegon A Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist. Eur J Pharmacol. 283:1995;19-29.
11. Feigenbaum JJ, Bergmann F, Richmond SA, Mechoulam R, Nadler V, Kloog Y, Sokolovsky M Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. Proc Natl Acad Sci USA. 86:1989;9584-9587.
12. Feuerstein GZ, Liu T, Barone FC Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc Brain Metab Rev. 6:1994;341-360.
13. Gallily R, Yamin A, Waksmann Y, Ovadia H, Weidenfeld J, Bar-Joseph A, Biegon A, Mechulam R, Shohami E Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid. J Pharmacol Exp Ther. 283:1997;918-924.
14. MacManus JP, Linnik MD Gene expression induced by cerebral ischemia: an apoptotic perspective. J Cereb Blood Flow Metab. 17:1997;815-832.
15. Margaill I, Allix M, Boulu RG, Plotkine M Dose- and time-dependence of L-NAME neuroprotection in transient focal cerebral ischaemia in rats. Br J Pharmacol. 120:1997;160-163.
16. McCulloch J Glutamate receptor antagonists in cerebral ischaemia. J Neural Transm Suppl. 43:1994;71-79.
17. Meistrell M, Botchinka G, Wang H, Di-Santo E, Cockroft K, Bloom O, Vishnubhakat J, Ghezzi P, Tracey K Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock. 8:1997;341-348.
18. Nawashiro H, Martin D, Hallenbeck JM Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J Cereb Blood Flow Metab. 17:1997;229-232.
19. Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab. 17:1997;483-490.
20. Olesen SP, Moller A, Mordvintcev PI, Busse R, Mulsch A Regional measurements of NO formed in vivo during brain ischemia. Acta Neurol Scand. 95:1997;219-224.
21. Sadoshima S, Nagao T, Okada Y, Fujii K, Ibayashi S, Fujishima M L-Arginine ameliorates recirculation and metabolic derangement in brain ischemia in hypertensive rats. Brain Res. 744:1997;246-252.
22. Saito K, Suyama K, Nishida K, Sei Y, Basile AS Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci Lett. 206:1996;149-152.
23. Samdani AF, Dawson TM, Dawson VL Nitric oxide synthase in models of focal ischemia. Stroke. 28:1997;1283-1288.
24. Scherbel U, Rhagupathi R, Nakamura M, Saatman K, McIntosh TK Evaluation of neurobehavioral deficits in brain-injured tumor necrosis factor deficient mice after experimental brain injury. J Neurotrauma. 7:1997;781.
25. Shohami E, Gallily R, Mechoulam R, Bass R, Ben Hur T Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant. J Neuroimmunol. 72:1997;169-177.
26. Shohami E, Novikov M, Bass R Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Res. 674:1995;55-62.
27. Shohami E, Novikov M, Mechoulam R A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat. J Neurotrauma. 10:1993;109-119.
28. Wityk RJ, Stern BJ Ischemic stroke: today and tomorrow. Crit Care Med. 22:1994;1278-1293.
29. Zhai QH, Futerll N, Chen FJ Gene expression of IL-10 in relationship to TNF alpha, IL-1beta, and IL-2 in the rat brain following middle cerebral artery occlusion. J Neurol Sci. 152(2):1997;1119-1124.